26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse

J Am Coll Cardiol. 1994 Oct;24(4):880-5. doi: 10.1016/0735-1097(94)90844-3.

Authors

B J Maron, J M Isner, W J McKenna

PMID: 7930220
DOI: 10.1016/0735-1097(94)90844-3

No abstract available

Publication types

Consensus Development Conference
Review

MeSH terms

Cardiomyopathies / diagnosis*
Cardiomyopathy, Hypertrophic / diagnosis*
Eligibility Determination*
Humans
Mitral Valve Prolapse / diagnosis*
Myocarditis / diagnosis*
Pericarditis / diagnosis*
Risk
Sports Medicine
Sports*